Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

RMD - Resmed Inc.


Close
245.02
1.860   0.759%

Share volume: 1,083,774
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$243.16
1.86
0.77%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
74%
Profitability 95%
Dept financing 26%
Liquidity 27%
Performance 76%
Company vs Stock growth
vs
Performance
5 Days
8.11%
1 Month
18.06%
3 Months
17.32%
6 Months
41.50%
1 Year
50.79%
2 Year
13.79%
Key data
Stock price
$245.02
P/E Ratio 
35.26
DAY RANGE
$242.48 - $246.22
EPS 
$6.92
52 WEEK RANGE
$130.88 - $246.80
52 WEEK CHANGE
$0.56
MARKET CAP 
36.001 B
YIELD 
0.80%
SHARES OUTSTANDING 
146.932 M
DIVIDEND
$0.53
EX-DIVIDEND DATE
08/15/2024
NEXT EARNINGS DATE
10/24/2024
BETA 
1.02
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$927,929
AVERAGE 30 VOLUME 
$1,008,230
Company detail
CEO: Michael Farrell
Region: US
Website: https://www.resmed.com/
Employees: 5,138
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.

Recent news